Proposed Data Collections Submitted for Public Comment and Recommendations, 65968 [E7-22930]

Download as PDF 65968 Federal Register / Vol. 72, No. 226 / Monday, November 26, 2007 / Notices Dated: November 16, 2007. Marilyn S. Radke, Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–22920 Filed 11–23–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30 Day–08–06AY] Proposed Data Collections Submitted for Public Comment and Recommendations The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Proposed Project Evaluation of the Spanish-Language Campaign ‘‘Good Morning Arthritis, Today You Will Not Defeat Us.’’— New—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description Arthritis affects nearly 43 million Americans, or about one in every five people, and is the leading cause of disability among adults in the United States. Limitations due to arthritis are particularly burdensome when they affect an individual’s mobility, productivity, and ability to earn a living, as well as psychological and social wellbeing. Because of the broad public health impact of this disease, the Centers for Disease Control and Prevention (CDC) developed the National Arthritis Action Plan in 1998 as a comprehensive approach to reducing the burden of arthritis in the United States. Hispanics are currently the fastest growing racial/ethnic group in the United States. Although Hispanic populations have a slightly lower prevalence rate of self-reported, doctordiagnosed arthritis than the general population, Hispanics with arthritis report greater work limitations, and higher rates of severe pain than do Caucasian populations with arthritis. CDC has developed a Spanish-language campaign, Good Morning Arthritis, Today you will not defeat us, to deliver culturally appropriate public health messages about the benefits of physical activity as an arthritis management strategy. Campaign materials include print ads, 30 and 60 second radio ads and public service announcements, and desktop displays with brochures for pharmacies, doctors’ offices, and community centers. The campaign is designed to reach Spanish speaking adults with arthritis who are aged 45– 64, who have high school education or less, and whose annual income is less than $35,000. CDC plans to conduct the campaign in four experimental markets. CDC requests clearance to conduct an evaluation of the campaign by collecting information from Spanish-speaking respondents in the four experimental markets and two control markets. An initial data collection will consist of telephone interviews, and will be based on a pre- and post-campaign evaluation design. A follow-up telephone interview, involving a subset of the initial respondents, will be conducted six months later. Results will be used to guide the public health practice of the 36 CDC-funded state arthritis programs and their partners. There are no costs to respondents other than their time. The estimated annualized burden hours are 2,730. ESTIMATED ANNUALIZED BURDEN HOURS Form name Target Population of Hispanic Adults ............. Screener for Primary Pre- and Post Campaign Survey. Primary Pre- and Post Campaign Survey ..... Screener for 6–Month Follow-up Survey ....... 6–Month Follow-up Survey ............................ Dated: November 16, 2007. Marilyn S. Radke, Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–22930 Filed 11–23–07; 8:45 am] mstockstill on PROD1PC66 with NOTICES BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. 2006P–0291, 2006P–0299, 2006P–0298, 2006P–0309, and 2007P–0062] Determination That ELOXATIN (Oxaliplatin for Injection), 50 and 100 Milligrams Per Vial, Sterile Lyophilized Powder for Injection, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness AGENCY: Food and Drug Administration, HHS. ACTION: VerDate Aug<31>2005 22:03 Nov 23, 2007 Jkt 214001 PO 00000 Notice. Frm 00032 Fmt 4703 Sfmt 4703 Number of responses per respondent Average burden per response (in hours) 60,000 1 2/60 2,400 2,400 600 1 1 1 13/60 2/60 13/60 Number of respondents Type of respondents SUMMARY: The Food and Drug Administration (FDA) has determined that ELOXATIN (oxaliplatin for injection), 50 and 100 milligrams (mg) per vial, sterile lyophilized powder for injection, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for oxaliplatin sterile lyophilized powder for injection, 50 and 100 mg/vial. FOR FURTHER INFORMATION CONTACT: Elizabeth Sadove, Center for Drug Evaluation and Research (HFD–7), Food and Drug Administration, 5600 Fishers E:\FR\FM\26NON1.SGM 26NON1

Agencies

[Federal Register Volume 72, Number 226 (Monday, November 26, 2007)]
[Notices]
[Page 65968]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-22930]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30 Day-08-06AY]

Proposed Data Collections Submitted for Public Comment and
Recommendations

The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.

Proposed Project

Evaluation of the Spanish-Language Campaign ``Good Morning
Arthritis, Today You Will Not Defeat Us.''--New--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).

Background and Brief Description

Arthritis affects nearly 43 million Americans, or about one in
every five people, and is the leading cause of disability among adults
in the United States. Limitations due to arthritis are particularly
burdensome when they affect an individual's mobility, productivity, and
ability to earn a living, as well as psychological and social well-
being. Because of the broad public health impact of this disease, the
Centers for Disease Control and Prevention (CDC) developed the National
Arthritis Action Plan in 1998 as a comprehensive approach to reducing
the burden of arthritis in the United States.
Hispanics are currently the fastest growing racial/ethnic group in
the United States. Although Hispanic populations have a slightly lower
prevalence rate of self-reported, doctor-diagnosed arthritis than the
general population, Hispanics with arthritis report greater work
limitations, and higher rates of severe pain than do Caucasian
populations with arthritis. CDC has developed a Spanish-language
campaign, Good Morning Arthritis, Today you will not defeat us, to
deliver culturally appropriate public health messages about the
benefits of physical activity as an arthritis management strategy.
Campaign materials include print ads, 30 and 60 second radio ads and
public service announcements, and desktop displays with brochures for
pharmacies, doctors' offices, and community centers. The campaign is
designed to reach Spanish speaking adults with arthritis who are aged
45-64, who have high school education or less, and whose annual income
is less than $35,000. CDC plans to conduct the campaign in four
experimental markets.
CDC requests clearance to conduct an evaluation of the campaign by
collecting information from Spanish-speaking respondents in the four
experimental markets and two control markets. An initial data
collection will consist of telephone interviews, and will be based on a
pre- and post-campaign evaluation design. A follow-up telephone
interview, involving a subset of the initial respondents, will be
conducted six months later. Results will be used to guide the public
health practice of the 36 CDC-funded state arthritis programs and their
partners.
There are no costs to respondents other than their time. The
estimated annualized burden hours are 2,730.

Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Target Population of Hispanic Adults.. Screener for Primary Pre- 60,000 1 2/60
and Post Campaign
Survey.
Primary Pre- and Post 2,400 1 13/60
Campaign Survey.
Screener for 6-Month 2,400 1 2/60
Follow-up Survey.
6-Month Follow-up Survey 600 1 13/60
----------------------------------------------------------------------------------------------------------------

Dated: November 16, 2007.
Marilyn S. Radke,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. E7-22930 Filed 11-23-07; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.